Pioglitazone and bladder cancer: the pros and cons.
K.J. Somaiya Medical College, Mumbai.
Vijay
V
Panikar
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D007194:India; D000077205:Pioglitazone; D018570:Risk Assessment; D045162:Thiazolidinediones / Q000009:adverse effects* / Q000627:therapeutic use*; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced*
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077205:Pioglitazone